Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Amanta Healthcare IPO
Price Band
₹120.0–126.0
Issue Size
₹126.0 Cr
Lot Size
119 shares
Min Investment
₹14,994
GMP
+₹9.0 (7.14%)
Issue Price
₹126.0
Subject to Sauda
₹800
Paid only if allotted
Amanta Healthcare IPO AI Summary
- Amanta Healthcare IPO is listed on BSE, NSE in the Pharmaceuticals sector.
- Price band: ₹120.0–₹126.0 per share, lot size 119 shares (min. investment ₹14,994).
- Subscription window: 01 Sep–03 Sep 2025, listing on 09 Sep 2025.
- Current GMP is +₹9.0 (7.14%), an estimated listing price of ₹135 — unofficial and can change daily.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Amanta Healthcare IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 03 Sep 2025 — not a current signal.
Reviewers are split — see individual calls below.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Amanta Healthcare IPO Grey Market Premium (GMP) Today
GMP
+₹9.0
GMP %
+7.14%
Est. Listing
₹135.0
Updated: 25 Jul 2026 14:13
About the Company
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilizing Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. The company is also a manufacturer of medical devices. The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment. The company markets products through three business units: National sales, International sales and Product partnering with various foreign and Indian pharmaceutical companies. The company manufactures over 45 generic products, marketing them under their brands in India through 320 distributors and stockists. The company sells products in Africa, Latin America, the UK, and beyond. Its products are registered in 19 countries and comply with various regulations. In Fiscal 2025, the company exported branded products to 21 countries. As of March 31, 2025, the company has a team of 1,718 employees at its formulation and development and quality laboratory. Competitive Strengths Well-established manufacturer of pharmaceutical formulations with a diverse product portfolio and diverse market. Large manufacturing capabilities Wide Domestic and International Marketing Network. Experienced management team supported by a large, diverse and skilled workforce.
Company Financials (₹ Cr)
As of 2025-03-31
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 381.76 | 352.12 | 374.06 |
| Total Income | 276.09 | 281.61 | 262.70 |
| Profit After Tax | 10.50 | 3.63 | -2.11 |
| EBITDA | 61.05 | 58.76 | 56.31 |
| NET Worth | 96.39 | 66.29 | 62.88 |
| Reserves and Surplus | 67.56 | 39.46 | 36.05 |
| Total Borrowing | 195.00 | 205.23 | 215.66 |
Key Ratios
EPS
₹3.64
NAV
₹33.43
ROE
12.42%
ROCE
13.72%
RoNW
10.89%
P/B Value
3.77
P/E Ratio
34.59
Market Cap
₹489.25 Cr
PAT Margin
3.86%
Debt/Equity
2.02
Peer Comparison
| Company | NAV | RoNW | P/E (x) | EPS Basic | EPS Diluted |
|---|---|---|---|---|---|
| Denis Chem Lab Ltd | 61.33 | 9.49% | 15.92 | 5.82 | 5.82 |
| Amanta Healthcare Limited This IPO | 33.43 | 10.89% | 33.92 | 3.71 | 3.71 |
Promoters
Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel and Milcent Appliances Pvt.Ltd.
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat 70.00 2 Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat 30.13 3 General Corporate Purposes 6.60 4 Issue Expenses 19.26 Total 126.00
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total Income was ₹262.70 Cr in the period ending 31 Mar 2023, rising to ₹281.61 Cr by 31 Mar 2024, though it decreased slightly to ₹276.09 Cr by 31 Mar 2025. This indicates a fluctuation in revenue over the periods.
Profit Trend
Profit After Tax was a loss of ₹2.11 Cr for the period ending 31 Mar 2023, improving to a profit of ₹3.63 Cr by 31 Mar 2024, and further increasing to ₹10.50 Cr by 31 Mar 2025. This demonstrates a positive trend in profitability over the periods.
Valuation
At the issue price of ₹126, Amanta Healthcare's implied P/E is approximately 34.59, compared to peers trading at a P/E of 15.92 for Denis Chem Lab Ltd.
Grey Market Premium, Explained
The Grey Market Premium (GMP) is an indicator of the potential listing gains of an IPO. It reflects the price at which shares are traded in the grey market before the official listing. A positive GMP suggests that the market anticipates a higher listing price compared to the issue price.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their investment goals and risk tolerance. It's important to consider the company's fundamentals and market conditions.
Who May Want to Wait
Investors who are risk-averse or prefer stable, established companies may want to avoid IPOs like this, which can be subject to market fluctuations and uncertainties.
IPO Timeline, Explained
The IPO opens for subscription on September 1, 2025, and closes on September 3, 2025. Allotment of shares will be done on September 4, 2025, with the listing date set for September 9, 2025.
Listing Gains — The Risk
Listing-day gains can be uncertain and are influenced by various factors, including market sentiment and demand for the shares. Investors should be prepared for potential volatility on the listing day.
This evaluation is generated from Amanta Healthcare's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Amanta Healthcare IPO GMP today?
Amanta Healthcare IPO GMP today is +₹9.0 (7.14%), indicating an estimated listing price of ₹135. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Amanta Healthcare IPO?
The price band of Amanta Healthcare IPO is ₹120.0–₹126.0 per share.
When does Amanta Healthcare IPO open and close?
Amanta Healthcare IPO opens on 01 September 2025 and closes on 03 September 2025.
When does Amanta Healthcare IPO list on the stock exchange?
Amanta Healthcare IPO listed on 09 September 2025 at ₹135.0.
What is the lot size for Amanta Healthcare IPO?
The lot size for Amanta Healthcare IPO is 119 shares, requiring a minimum investment of ₹14,994.
What is the price band for the Amanta Healthcare IPO?
The price band for the Amanta Healthcare IPO is ₹120 to ₹126.
What is the minimum investment required?
The minimum investment required is ₹14,994.
What is the lot size for this IPO?
The lot size for the Amanta Healthcare IPO is 119 shares.
When is the listing date for the IPO?
The listing date for the IPO is September 9, 2025.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected listing gains of the IPO based on unofficial trading in the grey market.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
01 Sep 2025
Close
03 Sep 2025
Allotment
04 Sep 2025
Listing
09 Sep 2025
Similar IPOs in Pharmaceuticals
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Amanta Healthcare?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.